Cantor Fitzgerald Reiterates “Overweight” Rating for Pfizer (NYSE:PFE)
Cantor Fitzgerald reiterated their overweight rating on shares of Pfizer (NYSE:PFE – Free Report) in a research report report published on Wednesday morning, Benzinga reports. Cantor Fitzgerald currently has a $45.00 target price on the biopharmaceutical company’s stock. Several other research analysts also recently weighed in on the stock. Barclays upped their price target on […]
More Stories
Columbia EM Core ex-China ETF (NYSEARCA:XCEM) Shares Purchased by CENTRAL TRUST Co
CENTRAL TRUST Co boosted its position in Columbia EM Core ex-China ETF (NYSEARCA:XCEM – Free Report) by 1.0% in the...
CENTRAL TRUST Co Grows Stock Holdings in BNY Mellon Core Bond ETF (NYSEARCA:BKAG)
CENTRAL TRUST Co increased its holdings in shares of BNY Mellon Core Bond ETF (NYSEARCA:BKAG – Free Report) by 31.9%...
Gibraltar Industries (ROCK) Set to Announce Quarterly Earnings on Wednesday
Gibraltar Industries (NASDAQ:ROCK – Get Free Report) will be posting its quarterly earnings results before the market opens on Wednesday,...
Kymera Therapeutics (KYMR) Scheduled to Post Earnings on Thursday
Kymera Therapeutics (NASDAQ:KYMR – Get Free Report) will issue its quarterly earnings data before the market opens on Thursday, October...
Amazon.com (NASDAQ:AMZN) Given Buy Rating at Needham & Company LLC
Amazon.com (NASDAQ:AMZN)‘s stock had its “buy” rating reaffirmed by stock analysts at Needham & Company LLC in a research report...
Beese Fulmer Investment Management Inc. Sells 151 Shares of Carrier Global Co. (NYSE:CARR)
Beese Fulmer Investment Management Inc. cut its position in Carrier Global Co. (NYSE:CARR – Free Report) by 0.8% in the...